nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.215	0.5	CpDpCtD
Bromocriptine—Parkinson's disease—Memantine—Alzheimer's disease	0.215	0.5	CpDpCtD
Bromocriptine—HTR6—Alzheimer's disease	0.187	0.773	CbGaD
Bromocriptine—HTR2A—Donepezil—Alzheimer's disease	0.0599	0.415	CbGbCtD
Bromocriptine—HTR2A—Alzheimer's disease	0.055	0.227	CbGaD
Bromocriptine—DRD2—Memantine—Alzheimer's disease	0.0478	0.331	CbGbCtD
Bromocriptine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0158	0.11	CbGbCtD
Bromocriptine—CYP3A4—Donepezil—Alzheimer's disease	0.0127	0.0877	CbGbCtD
Bromocriptine—CYP3A4—Galantamine—Alzheimer's disease	0.00816	0.0565	CbGbCtD
Bromocriptine—HTR2C—choroid plexus—Alzheimer's disease	0.0042	0.0934	CbGeAlD
Bromocriptine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00221	0.0492	CbGeAlD
Bromocriptine—HTR2A—choroid plexus—Alzheimer's disease	0.00211	0.0469	CbGeAlD
Bromocriptine—HTR7—locus ceruleus—Alzheimer's disease	0.00209	0.0464	CbGeAlD
Bromocriptine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00158	0.0352	CbGeAlD
Bromocriptine—HTR2A—locus ceruleus—Alzheimer's disease	0.0013	0.029	CbGeAlD
Bromocriptine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00128	0.0286	CbGeAlD
Bromocriptine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00124	0.0276	CbGeAlD
Bromocriptine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00123	0.0274	CbGeAlD
Bromocriptine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00106	0.0236	CbGeAlD
Bromocriptine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00103	0.023	CbGeAlD
Bromocriptine—HTR7—telencephalic ventricle—Alzheimer's disease	0.000989	0.022	CbGeAlD
Bromocriptine—DRD2—telencephalic ventricle—Alzheimer's disease	0.000935	0.0208	CbGeAlD
Bromocriptine—Dihydroergotamine—HTR6—Alzheimer's disease	0.000858	0.444	CrCbGaD
Bromocriptine—HTR1B—blood vessel—Alzheimer's disease	0.000635	0.0141	CbGeAlD
Bromocriptine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000617	0.0137	CbGeAlD
Bromocriptine—HTR1D—blood vessel—Alzheimer's disease	0.000614	0.0137	CbGeAlD
Bromocriptine—Methysergide—HTR6—Alzheimer's disease	0.000572	0.297	CrCbGaD
Bromocriptine—HTR6—forebrain—Alzheimer's disease	0.000556	0.0124	CbGeAlD
Bromocriptine—DRD5—forebrain—Alzheimer's disease	0.000541	0.012	CbGeAlD
Bromocriptine—HTR6—telencephalon—Alzheimer's disease	0.000511	0.0114	CbGeAlD
Bromocriptine—DRD5—telencephalon—Alzheimer's disease	0.000497	0.0111	CbGeAlD
Bromocriptine—HTR7—blood vessel—Alzheimer's disease	0.000489	0.0109	CbGeAlD
Bromocriptine—ADRA1D—forebrain—Alzheimer's disease	0.000434	0.00966	CbGeAlD
Bromocriptine—DRD1—forebrain—Alzheimer's disease	0.000413	0.0092	CbGeAlD
Bromocriptine—ADRA1D—telencephalon—Alzheimer's disease	0.000399	0.00888	CbGeAlD
Bromocriptine—DRD1—telencephalon—Alzheimer's disease	0.00038	0.00846	CbGeAlD
Bromocriptine—DRD4—brain—Alzheimer's disease	0.000341	0.00759	CbGeAlD
Bromocriptine—HTR1B—forebrain—Alzheimer's disease	0.000335	0.00746	CbGeAlD
Bromocriptine—HTR1D—forebrain—Alzheimer's disease	0.000324	0.00722	CbGeAlD
Bromocriptine—HTR2C—forebrain—Alzheimer's disease	0.000321	0.00715	CbGeAlD
Bromocriptine—ADRB1—forebrain—Alzheimer's disease	0.000315	0.00701	CbGeAlD
Bromocriptine—DRD3—nervous system—Alzheimer's disease	0.000313	0.00698	CbGeAlD
Bromocriptine—HTR1B—telencephalon—Alzheimer's disease	0.000308	0.00686	CbGeAlD
Bromocriptine—HTR2A—blood vessel—Alzheimer's disease	0.000305	0.0068	CbGeAlD
Bromocriptine—DRD3—central nervous system—Alzheimer's disease	0.000302	0.00672	CbGeAlD
Bromocriptine—HTR6—nervous system—Alzheimer's disease	0.000302	0.00672	CbGeAlD
Bromocriptine—HTR2B—forebrain—Alzheimer's disease	0.000302	0.00671	CbGeAlD
Bromocriptine—HTR1D—telencephalon—Alzheimer's disease	0.000298	0.00664	CbGeAlD
Bromocriptine—HTR2C—telencephalon—Alzheimer's disease	0.000295	0.00657	CbGeAlD
Bromocriptine—DRD5—nervous system—Alzheimer's disease	0.000294	0.00654	CbGeAlD
Bromocriptine—HTR6—central nervous system—Alzheimer's disease	0.00029	0.00647	CbGeAlD
Bromocriptine—ADRB1—telencephalon—Alzheimer's disease	0.00029	0.00645	CbGeAlD
Bromocriptine—DRD5—central nervous system—Alzheimer's disease	0.000283	0.00629	CbGeAlD
Bromocriptine—HTR2B—telencephalon—Alzheimer's disease	0.000277	0.00617	CbGeAlD
Bromocriptine—HTR1A—forebrain—Alzheimer's disease	0.00027	0.00602	CbGeAlD
Bromocriptine—HTR7—forebrain—Alzheimer's disease	0.000258	0.00575	CbGeAlD
Bromocriptine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00025	0.00295	CcSEcCtD
Bromocriptine—Oedema peripheral—Galantamine—Alzheimer's disease	0.00025	0.00294	CcSEcCtD
Bromocriptine—ADRA1A—forebrain—Alzheimer's disease	0.000249	0.00555	CbGeAlD
Bromocriptine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000249	0.00293	CcSEcCtD
Bromocriptine—HTR1A—telencephalon—Alzheimer's disease	0.000248	0.00553	CbGeAlD
Bromocriptine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000246	0.0029	CcSEcCtD
Bromocriptine—Influenza—Donepezil—Alzheimer's disease	0.000245	0.00289	CcSEcCtD
Bromocriptine—Dysphagia—Donepezil—Alzheimer's disease	0.000245	0.00289	CcSEcCtD
Bromocriptine—Urinary retention—Memantine—Alzheimer's disease	0.000245	0.00289	CcSEcCtD
Bromocriptine—Visual impairment—Galantamine—Alzheimer's disease	0.000244	0.00288	CcSEcCtD
Bromocriptine—DRD2—forebrain—Alzheimer's disease	0.000244	0.00544	CbGeAlD
Bromocriptine—Ataxia—Memantine—Alzheimer's disease	0.000242	0.00285	CcSEcCtD
Bromocriptine—ADRA1B—nervous system—Alzheimer's disease	0.000241	0.00536	CbGeAlD
Bromocriptine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00024	0.00282	CcSEcCtD
Bromocriptine—DRD3—brain—Alzheimer's disease	0.000239	0.00533	CbGeAlD
Bromocriptine—HTR7—telencephalon—Alzheimer's disease	0.000237	0.00529	CbGeAlD
Bromocriptine—Ataxia—Rivastigmine—Alzheimer's disease	0.000237	0.00279	CcSEcCtD
Bromocriptine—Eye disorder—Galantamine—Alzheimer's disease	0.000237	0.00279	CcSEcCtD
Bromocriptine—Tinnitus—Galantamine—Alzheimer's disease	0.000236	0.00278	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000235	0.00277	CcSEcCtD
Bromocriptine—ADRA1D—nervous system—Alzheimer's disease	0.000235	0.00524	CbGeAlD
Bromocriptine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000235	0.00277	CcSEcCtD
Bromocriptine—Cardiac disorder—Galantamine—Alzheimer's disease	0.000235	0.00277	CcSEcCtD
Bromocriptine—ADRA1B—central nervous system—Alzheimer's disease	0.000232	0.00516	CbGeAlD
Bromocriptine—Nasopharyngitis—Memantine—Alzheimer's disease	0.000231	0.00271	CcSEcCtD
Bromocriptine—HTR6—brain—Alzheimer's disease	0.000231	0.00513	CbGeAlD
Bromocriptine—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00023	0.00271	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00023	0.00271	CcSEcCtD
Bromocriptine—Angiopathy—Galantamine—Alzheimer's disease	0.00023	0.00271	CcSEcCtD
Bromocriptine—ADRA1A—telencephalon—Alzheimer's disease	0.000229	0.0051	CbGeAlD
Bromocriptine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000227	0.00267	CcSEcCtD
Bromocriptine—Pollakiuria—Donepezil—Alzheimer's disease	0.000227	0.00267	CcSEcCtD
Bromocriptine—ADRA1D—central nervous system—Alzheimer's disease	0.000227	0.00505	CbGeAlD
Bromocriptine—Arrhythmia—Galantamine—Alzheimer's disease	0.000226	0.00267	CcSEcCtD
Bromocriptine—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000226	0.00265	CcSEcCtD
Bromocriptine—DRD2—telencephalon—Alzheimer's disease	0.000225	0.005	CbGeAlD
Bromocriptine—DRD5—brain—Alzheimer's disease	0.000224	0.005	CbGeAlD
Bromocriptine—DRD1—nervous system—Alzheimer's disease	0.000224	0.005	CbGeAlD
Bromocriptine—Dysphagia—Memantine—Alzheimer's disease	0.000223	0.00262	CcSEcCtD
Bromocriptine—Influenza—Memantine—Alzheimer's disease	0.000223	0.00262	CcSEcCtD
Bromocriptine—Mental disorder—Galantamine—Alzheimer's disease	0.000222	0.00261	CcSEcCtD
Bromocriptine—ADRA2C—telencephalon—Alzheimer's disease	0.000218	0.00486	CbGeAlD
Bromocriptine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000218	0.00257	CcSEcCtD
Bromocriptine—Tension—Galantamine—Alzheimer's disease	0.000217	0.00255	CcSEcCtD
Bromocriptine—Dysgeusia—Galantamine—Alzheimer's disease	0.000216	0.00254	CcSEcCtD
Bromocriptine—DRD1—central nervous system—Alzheimer's disease	0.000216	0.00481	CbGeAlD
Bromocriptine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000216	0.00254	CcSEcCtD
Bromocriptine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000214	0.00252	CcSEcCtD
Bromocriptine—Nervousness—Galantamine—Alzheimer's disease	0.000214	0.00252	CcSEcCtD
Bromocriptine—Muscle spasms—Galantamine—Alzheimer's disease	0.000212	0.0025	CcSEcCtD
Bromocriptine—Vision blurred—Galantamine—Alzheimer's disease	0.000208	0.00245	CcSEcCtD
Bromocriptine—Pollakiuria—Memantine—Alzheimer's disease	0.000206	0.00242	CcSEcCtD
Bromocriptine—Agitation—Galantamine—Alzheimer's disease	0.000203	0.00239	CcSEcCtD
Bromocriptine—Methylergometrine—HTR2A—Alzheimer's disease	0.000202	0.105	CrCbGaD
Bromocriptine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000201	0.00237	CcSEcCtD
Bromocriptine—ABCB1—blood vessel—Alzheimer's disease	0.0002	0.00445	CbGeAlD
Bromocriptine—Bradycardia—Donepezil—Alzheimer's disease	0.0002	0.00235	CcSEcCtD
Bromocriptine—Vertigo—Galantamine—Alzheimer's disease	0.000198	0.00233	CcSEcCtD
Bromocriptine—Syncope—Galantamine—Alzheimer's disease	0.000198	0.00233	CcSEcCtD
Bromocriptine—Rhinitis—Donepezil—Alzheimer's disease	0.000197	0.00232	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000196	0.00231	CcSEcCtD
Bromocriptine—Hallucination—Donepezil—Alzheimer's disease	0.000195	0.0023	CcSEcCtD
Bromocriptine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000195	0.0023	CcSEcCtD
Bromocriptine—Myocardial infarction—Memantine—Alzheimer's disease	0.000195	0.00229	CcSEcCtD
Bromocriptine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000194	0.00229	CcSEcCtD
Bromocriptine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000194	0.00228	CcSEcCtD
Bromocriptine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000194	0.00228	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000192	0.00226	CcSEcCtD
Bromocriptine—Convulsion—Galantamine—Alzheimer's disease	0.000191	0.00225	CcSEcCtD
Bromocriptine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000191	0.00224	CcSEcCtD
Bromocriptine—Hypertension—Galantamine—Alzheimer's disease	0.00019	0.00224	CcSEcCtD
Bromocriptine—ADRA2A—forebrain—Alzheimer's disease	0.000189	0.00422	CbGeAlD
Bromocriptine—Visual impairment—Donepezil—Alzheimer's disease	0.000189	0.00223	CcSEcCtD
Bromocriptine—Anxiety—Galantamine—Alzheimer's disease	0.000187	0.0022	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000187	0.0022	CcSEcCtD
Bromocriptine—Sinusitis—Memantine—Alzheimer's disease	0.000186	0.00219	CcSEcCtD
Bromocriptine—ADRA1B—brain—Alzheimer's disease	0.000184	0.0041	CbGeAlD
Bromocriptine—Dry mouth—Galantamine—Alzheimer's disease	0.000184	0.00216	CcSEcCtD
Bromocriptine—Tinnitus—Donepezil—Alzheimer's disease	0.000183	0.00216	CcSEcCtD
Bromocriptine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000182	0.00215	CcSEcCtD
Bromocriptine—HTR2A—embryo—Alzheimer's disease	0.000182	0.00405	CbGeAlD
Bromocriptine—HTR1B—nervous system—Alzheimer's disease	0.000182	0.00405	CbGeAlD
Bromocriptine—Confusional state—Galantamine—Alzheimer's disease	0.000182	0.00214	CcSEcCtD
Bromocriptine—Bradycardia—Memantine—Alzheimer's disease	0.000182	0.00214	CcSEcCtD
Bromocriptine—ADRA1D—brain—Alzheimer's disease	0.00018	0.00401	CbGeAlD
Bromocriptine—Rhinitis—Memantine—Alzheimer's disease	0.000179	0.0021	CcSEcCtD
Bromocriptine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000178	0.00209	CcSEcCtD
Bromocriptine—Hallucination—Memantine—Alzheimer's disease	0.000177	0.00209	CcSEcCtD
Bromocriptine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000177	0.00209	CcSEcCtD
Bromocriptine—Shock—Galantamine—Alzheimer's disease	0.000177	0.00209	CcSEcCtD
Bromocriptine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000177	0.00208	CcSEcCtD
Bromocriptine—HTR1D—nervous system—Alzheimer's disease	0.000176	0.00392	CbGeAlD
Bromocriptine—Tachycardia—Galantamine—Alzheimer's disease	0.000176	0.00207	CcSEcCtD
Bromocriptine—Oedema peripheral—Memantine—Alzheimer's disease	0.000176	0.00207	CcSEcCtD
Bromocriptine—Arrhythmia—Donepezil—Alzheimer's disease	0.000175	0.00207	CcSEcCtD
Bromocriptine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000175	0.00206	CcSEcCtD
Bromocriptine—HTR1B—central nervous system—Alzheimer's disease	0.000175	0.0039	CbGeAlD
Bromocriptine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000175	0.00206	CcSEcCtD
Bromocriptine—Skin disorder—Galantamine—Alzheimer's disease	0.000175	0.00206	CcSEcCtD
Bromocriptine—HTR2C—nervous system—Alzheimer's disease	0.000174	0.00388	CbGeAlD
Bromocriptine—ADRA2A—telencephalon—Alzheimer's disease	0.000174	0.00388	CbGeAlD
Bromocriptine—Hallucination—Rivastigmine—Alzheimer's disease	0.000174	0.00204	CcSEcCtD
Bromocriptine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000174	0.00204	CcSEcCtD
Bromocriptine—Alopecia—Donepezil—Alzheimer's disease	0.000174	0.00204	CcSEcCtD
Bromocriptine—Mental disorder—Donepezil—Alzheimer's disease	0.000172	0.00203	CcSEcCtD
Bromocriptine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000172	0.00202	CcSEcCtD
Bromocriptine—Visual impairment—Memantine—Alzheimer's disease	0.000172	0.00202	CcSEcCtD
Bromocriptine—Anorexia—Galantamine—Alzheimer's disease	0.000172	0.00202	CcSEcCtD
Bromocriptine—DRD1—brain—Alzheimer's disease	0.000171	0.00382	CbGeAlD
Bromocriptine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000171	0.00202	CcSEcCtD
Bromocriptine—ADRB1—nervous system—Alzheimer's disease	0.000171	0.00381	CbGeAlD
Bromocriptine—HTR1D—central nervous system—Alzheimer's disease	0.000169	0.00377	CbGeAlD
Bromocriptine—Methysergide—HTR2A—Alzheimer's disease	0.000168	0.0872	CrCbGaD
Bromocriptine—Hypotension—Galantamine—Alzheimer's disease	0.000168	0.00198	CcSEcCtD
Bromocriptine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000168	0.00198	CcSEcCtD
Bromocriptine—Tension—Donepezil—Alzheimer's disease	0.000168	0.00198	CcSEcCtD
Bromocriptine—HTR2C—central nervous system—Alzheimer's disease	0.000168	0.00374	CbGeAlD
Bromocriptine—Dysgeusia—Donepezil—Alzheimer's disease	0.000167	0.00197	CcSEcCtD
Bromocriptine—Eye disorder—Memantine—Alzheimer's disease	0.000167	0.00196	CcSEcCtD
Bromocriptine—Tinnitus—Memantine—Alzheimer's disease	0.000166	0.00196	CcSEcCtD
Bromocriptine—Nervousness—Donepezil—Alzheimer's disease	0.000166	0.00196	CcSEcCtD
Bromocriptine—Cardiac disorder—Memantine—Alzheimer's disease	0.000166	0.00195	CcSEcCtD
Bromocriptine—ADRB1—central nervous system—Alzheimer's disease	0.000165	0.00367	CbGeAlD
Bromocriptine—Muscle spasms—Donepezil—Alzheimer's disease	0.000164	0.00194	CcSEcCtD
Bromocriptine—HTR2B—nervous system—Alzheimer's disease	0.000164	0.00365	CbGeAlD
Bromocriptine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000163	0.00192	CcSEcCtD
Bromocriptine—Insomnia—Galantamine—Alzheimer's disease	0.000163	0.00192	CcSEcCtD
Bromocriptine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000163	0.00192	CcSEcCtD
Bromocriptine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000162	0.00191	CcSEcCtD
Bromocriptine—Angiopathy—Memantine—Alzheimer's disease	0.000162	0.0019	CcSEcCtD
Bromocriptine—Paraesthesia—Galantamine—Alzheimer's disease	0.000162	0.0019	CcSEcCtD
Bromocriptine—Vision blurred—Donepezil—Alzheimer's disease	0.000161	0.0019	CcSEcCtD
Bromocriptine—HTR2A—forebrain—Alzheimer's disease	0.000161	0.00359	CbGeAlD
Bromocriptine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000161	0.00189	CcSEcCtD
Bromocriptine—Somnolence—Galantamine—Alzheimer's disease	0.00016	0.00188	CcSEcCtD
Bromocriptine—Arrhythmia—Memantine—Alzheimer's disease	0.000159	0.00188	CcSEcCtD
Bromocriptine—Dyspepsia—Galantamine—Alzheimer's disease	0.000159	0.00187	CcSEcCtD
Bromocriptine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000158	0.00186	CcSEcCtD
Bromocriptine—HTR2B—central nervous system—Alzheimer's disease	0.000158	0.00351	CbGeAlD
Bromocriptine—Alopecia—Memantine—Alzheimer's disease	0.000158	0.00186	CcSEcCtD
Bromocriptine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000157	0.00185	CcSEcCtD
Bromocriptine—Agitation—Donepezil—Alzheimer's disease	0.000157	0.00185	CcSEcCtD
Bromocriptine—Decreased appetite—Galantamine—Alzheimer's disease	0.000157	0.00184	CcSEcCtD
Bromocriptine—Mental disorder—Memantine—Alzheimer's disease	0.000156	0.00184	CcSEcCtD
Bromocriptine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000156	0.00183	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000155	0.00183	CcSEcCtD
Bromocriptine—Fatigue—Galantamine—Alzheimer's disease	0.000155	0.00183	CcSEcCtD
Bromocriptine—Alopecia—Rivastigmine—Alzheimer's disease	0.000154	0.00182	CcSEcCtD
Bromocriptine—Constipation—Galantamine—Alzheimer's disease	0.000154	0.00181	CcSEcCtD
Bromocriptine—Vertigo—Donepezil—Alzheimer's disease	0.000154	0.00181	CcSEcCtD
Bromocriptine—Syncope—Donepezil—Alzheimer's disease	0.000153	0.00181	CcSEcCtD
Bromocriptine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000153	0.0018	CcSEcCtD
Bromocriptine—Tension—Memantine—Alzheimer's disease	0.000152	0.00179	CcSEcCtD
Bromocriptine—Dysgeusia—Memantine—Alzheimer's disease	0.000152	0.00179	CcSEcCtD
Bromocriptine—Nervousness—Memantine—Alzheimer's disease	0.000151	0.00178	CcSEcCtD
Bromocriptine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00015	0.00177	CcSEcCtD
Bromocriptine—Tension—Rivastigmine—Alzheimer's disease	0.000149	0.00175	CcSEcCtD
Bromocriptine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000149	0.00175	CcSEcCtD
Bromocriptine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000148	0.00175	CcSEcCtD
Bromocriptine—Convulsion—Donepezil—Alzheimer's disease	0.000148	0.00174	CcSEcCtD
Bromocriptine—HTR2A—telencephalon—Alzheimer's disease	0.000148	0.0033	CbGeAlD
Bromocriptine—Hypertension—Donepezil—Alzheimer's disease	0.000148	0.00174	CcSEcCtD
Bromocriptine—Nervousness—Rivastigmine—Alzheimer's disease	0.000148	0.00174	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000147	0.00173	CcSEcCtD
Bromocriptine—HTR1A—nervous system—Alzheimer's disease	0.000147	0.00327	CbGeAlD
Bromocriptine—Vision blurred—Memantine—Alzheimer's disease	0.000146	0.00172	CcSEcCtD
Bromocriptine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000146	0.00172	CcSEcCtD
Bromocriptine—Anxiety—Donepezil—Alzheimer's disease	0.000145	0.00171	CcSEcCtD
Bromocriptine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000143	0.00169	CcSEcCtD
Bromocriptine—Agitation—Memantine—Alzheimer's disease	0.000143	0.00168	CcSEcCtD
Bromocriptine—Dry mouth—Donepezil—Alzheimer's disease	0.000142	0.00168	CcSEcCtD
Bromocriptine—Body temperature increased—Galantamine—Alzheimer's disease	0.000142	0.00168	CcSEcCtD
Bromocriptine—Abdominal pain—Galantamine—Alzheimer's disease	0.000142	0.00168	CcSEcCtD
Bromocriptine—HTR1A—central nervous system—Alzheimer's disease	0.000141	0.00314	CbGeAlD
Bromocriptine—Confusional state—Donepezil—Alzheimer's disease	0.000141	0.00166	CcSEcCtD
Bromocriptine—HTR7—nervous system—Alzheimer's disease	0.00014	0.00312	CbGeAlD
Bromocriptine—Agitation—Rivastigmine—Alzheimer's disease	0.00014	0.00164	CcSEcCtD
Bromocriptine—Oedema—Donepezil—Alzheimer's disease	0.00014	0.00164	CcSEcCtD
Bromocriptine—Vertigo—Memantine—Alzheimer's disease	0.000139	0.00164	CcSEcCtD
Bromocriptine—Syncope—Memantine—Alzheimer's disease	0.000139	0.00164	CcSEcCtD
Bromocriptine—HTR1B—brain—Alzheimer's disease	0.000139	0.00309	CbGeAlD
Bromocriptine—Infection—Donepezil—Alzheimer's disease	0.000139	0.00163	CcSEcCtD
Bromocriptine—HTR1A—cerebellum—Alzheimer's disease	0.000138	0.00307	CbGeAlD
Bromocriptine—Shock—Donepezil—Alzheimer's disease	0.000137	0.00162	CcSEcCtD
Bromocriptine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000137	0.00161	CcSEcCtD
Bromocriptine—Vertigo—Rivastigmine—Alzheimer's disease	0.000136	0.00161	CcSEcCtD
Bromocriptine—Loss of consciousness—Memantine—Alzheimer's disease	0.000136	0.00161	CcSEcCtD
Bromocriptine—Syncope—Rivastigmine—Alzheimer's disease	0.000136	0.0016	CcSEcCtD
Bromocriptine—ADRA1A—nervous system—Alzheimer's disease	0.000135	0.00301	CbGeAlD
Bromocriptine—HTR7—central nervous system—Alzheimer's disease	0.000135	0.00301	CbGeAlD
Bromocriptine—HTR1D—brain—Alzheimer's disease	0.000135	0.003	CbGeAlD
Bromocriptine—Convulsion—Memantine—Alzheimer's disease	0.000135	0.00158	CcSEcCtD
Bromocriptine—Hypertension—Memantine—Alzheimer's disease	0.000134	0.00158	CcSEcCtD
Bromocriptine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000133	0.00157	CcSEcCtD
Bromocriptine—HTR2C—brain—Alzheimer's disease	0.000133	0.00297	CbGeAlD
Bromocriptine—Anorexia—Donepezil—Alzheimer's disease	0.000133	0.00157	CcSEcCtD
Bromocriptine—DRD2—nervous system—Alzheimer's disease	0.000133	0.00295	CbGeAlD
Bromocriptine—HTR7—cerebellum—Alzheimer's disease	0.000132	0.00294	CbGeAlD
Bromocriptine—Anxiety—Memantine—Alzheimer's disease	0.000132	0.00155	CcSEcCtD
Bromocriptine—Convulsion—Rivastigmine—Alzheimer's disease	0.000132	0.00155	CcSEcCtD
Bromocriptine—Hypertension—Rivastigmine—Alzheimer's disease	0.000131	0.00154	CcSEcCtD
Bromocriptine—ADRB1—brain—Alzheimer's disease	0.000131	0.00291	CbGeAlD
Bromocriptine—Hypotension—Donepezil—Alzheimer's disease	0.00013	0.00154	CcSEcCtD
Bromocriptine—ADRA1A—central nervous system—Alzheimer's disease	0.00013	0.0029	CbGeAlD
Bromocriptine—Ergotamine—HTR2A—Alzheimer's disease	0.00013	0.0673	CrCbGaD
Bromocriptine—Dry mouth—Memantine—Alzheimer's disease	0.000129	0.00152	CcSEcCtD
Bromocriptine—Asthenia—Galantamine—Alzheimer's disease	0.000129	0.00152	CcSEcCtD
Bromocriptine—Anxiety—Rivastigmine—Alzheimer's disease	0.000129	0.00152	CcSEcCtD
Bromocriptine—ADRA2C—nervous system—Alzheimer's disease	0.000129	0.00287	CbGeAlD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000128	0.00151	CcSEcCtD
Bromocriptine—Confusional state—Memantine—Alzheimer's disease	0.000128	0.0015	CcSEcCtD
Bromocriptine—DRD2—central nervous system—Alzheimer's disease	0.000128	0.00284	CbGeAlD
Bromocriptine—ADRA1A—cerebellum—Alzheimer's disease	0.000127	0.00283	CbGeAlD
Bromocriptine—Oedema—Memantine—Alzheimer's disease	0.000127	0.00149	CcSEcCtD
Bromocriptine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000126	0.00149	CcSEcCtD
Bromocriptine—Insomnia—Donepezil—Alzheimer's disease	0.000126	0.00149	CcSEcCtD
Bromocriptine—Infection—Memantine—Alzheimer's disease	0.000126	0.00148	CcSEcCtD
Bromocriptine—Paraesthesia—Donepezil—Alzheimer's disease	0.000125	0.00148	CcSEcCtD
Bromocriptine—HTR2B—brain—Alzheimer's disease	0.000125	0.00279	CbGeAlD
Bromocriptine—Confusional state—Rivastigmine—Alzheimer's disease	0.000125	0.00147	CcSEcCtD
Bromocriptine—DRD2—cerebellum—Alzheimer's disease	0.000125	0.00278	CbGeAlD
Bromocriptine—Shock—Memantine—Alzheimer's disease	0.000125	0.00147	CcSEcCtD
Bromocriptine—Dyspnoea—Donepezil—Alzheimer's disease	0.000124	0.00146	CcSEcCtD
Bromocriptine—Nervous system disorder—Memantine—Alzheimer's disease	0.000124	0.00146	CcSEcCtD
Bromocriptine—Somnolence—Donepezil—Alzheimer's disease	0.000124	0.00146	CcSEcCtD
Bromocriptine—ADRA2C—central nervous system—Alzheimer's disease	0.000124	0.00276	CbGeAlD
Bromocriptine—Oedema—Rivastigmine—Alzheimer's disease	0.000124	0.00146	CcSEcCtD
Bromocriptine—Tachycardia—Memantine—Alzheimer's disease	0.000124	0.00146	CcSEcCtD
Bromocriptine—Diarrhoea—Galantamine—Alzheimer's disease	0.000123	0.00145	CcSEcCtD
Bromocriptine—Infection—Rivastigmine—Alzheimer's disease	0.000123	0.00145	CcSEcCtD
Bromocriptine—Skin disorder—Memantine—Alzheimer's disease	0.000123	0.00145	CcSEcCtD
Bromocriptine—Dyspepsia—Donepezil—Alzheimer's disease	0.000123	0.00145	CcSEcCtD
Bromocriptine—Shock—Rivastigmine—Alzheimer's disease	0.000122	0.00144	CcSEcCtD
Bromocriptine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000122	0.00143	CcSEcCtD
Bromocriptine—Decreased appetite—Donepezil—Alzheimer's disease	0.000121	0.00143	CcSEcCtD
Bromocriptine—ADRA2C—cerebellum—Alzheimer's disease	0.000121	0.0027	CbGeAlD
Bromocriptine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000121	0.00142	CcSEcCtD
Bromocriptine—Anorexia—Memantine—Alzheimer's disease	0.000121	0.00142	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00012	0.00142	CcSEcCtD
Bromocriptine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00012	0.00142	CcSEcCtD
Bromocriptine—Fatigue—Donepezil—Alzheimer's disease	0.00012	0.00142	CcSEcCtD
Bromocriptine—Constipation—Donepezil—Alzheimer's disease	0.000119	0.0014	CcSEcCtD
Bromocriptine—ABCB1—embryo—Alzheimer's disease	0.000119	0.00266	CbGeAlD
Bromocriptine—Dizziness—Galantamine—Alzheimer's disease	0.000119	0.0014	CcSEcCtD
Bromocriptine—Hypotension—Memantine—Alzheimer's disease	0.000118	0.00139	CcSEcCtD
Bromocriptine—Anorexia—Rivastigmine—Alzheimer's disease	0.000118	0.00139	CcSEcCtD
Bromocriptine—Hypotension—Rivastigmine—Alzheimer's disease	0.000116	0.00136	CcSEcCtD
Bromocriptine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000115	0.00135	CcSEcCtD
Bromocriptine—Insomnia—Memantine—Alzheimer's disease	0.000115	0.00135	CcSEcCtD
Bromocriptine—Vomiting—Galantamine—Alzheimer's disease	0.000114	0.00135	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000114	0.00134	CcSEcCtD
Bromocriptine—Paraesthesia—Memantine—Alzheimer's disease	0.000114	0.00134	CcSEcCtD
Bromocriptine—Rash—Galantamine—Alzheimer's disease	0.000114	0.00134	CcSEcCtD
Bromocriptine—Dermatitis—Galantamine—Alzheimer's disease	0.000113	0.00134	CcSEcCtD
Bromocriptine—Dyspnoea—Memantine—Alzheimer's disease	0.000113	0.00133	CcSEcCtD
Bromocriptine—Headache—Galantamine—Alzheimer's disease	0.000113	0.00133	CcSEcCtD
Bromocriptine—Somnolence—Memantine—Alzheimer's disease	0.000113	0.00133	CcSEcCtD
Bromocriptine—HTR1A—brain—Alzheimer's disease	0.000112	0.0025	CbGeAlD
Bromocriptine—Insomnia—Rivastigmine—Alzheimer's disease	0.000112	0.00132	CcSEcCtD
Bromocriptine—Dyspepsia—Memantine—Alzheimer's disease	0.000112	0.00131	CcSEcCtD
Bromocriptine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000111	0.00131	CcSEcCtD
Bromocriptine—Urticaria—Donepezil—Alzheimer's disease	0.000111	0.00131	CcSEcCtD
Bromocriptine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000111	0.0013	CcSEcCtD
Bromocriptine—Abdominal pain—Donepezil—Alzheimer's disease	0.00011	0.0013	CcSEcCtD
Bromocriptine—Body temperature increased—Donepezil—Alzheimer's disease	0.00011	0.0013	CcSEcCtD
Bromocriptine—Somnolence—Rivastigmine—Alzheimer's disease	0.00011	0.0013	CcSEcCtD
Bromocriptine—Decreased appetite—Memantine—Alzheimer's disease	0.00011	0.0013	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000109	0.00129	CcSEcCtD
Bromocriptine—Fatigue—Memantine—Alzheimer's disease	0.000109	0.00129	CcSEcCtD
Bromocriptine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000109	0.00128	CcSEcCtD
Bromocriptine—Constipation—Memantine—Alzheimer's disease	0.000108	0.00128	CcSEcCtD
Bromocriptine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000108	0.00127	CcSEcCtD
Bromocriptine—HTR7—brain—Alzheimer's disease	0.000107	0.00239	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000107	0.00126	CcSEcCtD
Bromocriptine—Nausea—Galantamine—Alzheimer's disease	0.000107	0.00126	CcSEcCtD
Bromocriptine—Fatigue—Rivastigmine—Alzheimer's disease	0.000107	0.00126	CcSEcCtD
Bromocriptine—Constipation—Rivastigmine—Alzheimer's disease	0.000106	0.00125	CcSEcCtD
Bromocriptine—ABCB1—forebrain—Alzheimer's disease	0.000106	0.00235	CbGeAlD
Bromocriptine—Feeling abnormal—Memantine—Alzheimer's disease	0.000104	0.00123	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000104	0.00122	CcSEcCtD
Bromocriptine—ADRA1A—brain—Alzheimer's disease	0.000103	0.0023	CbGeAlD
Bromocriptine—ADRA2A—nervous system—Alzheimer's disease	0.000103	0.00229	CbGeAlD
Bromocriptine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000102	0.0012	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000101	0.00119	CcSEcCtD
Bromocriptine—DRD2—brain—Alzheimer's disease	0.000101	0.00226	CbGeAlD
Bromocriptine—Urticaria—Memantine—Alzheimer's disease	0.000101	0.00119	CcSEcCtD
Bromocriptine—Body temperature increased—Memantine—Alzheimer's disease	0.0001	0.00118	CcSEcCtD
Bromocriptine—Abdominal pain—Memantine—Alzheimer's disease	0.0001	0.00118	CcSEcCtD
Bromocriptine—Asthenia—Donepezil—Alzheimer's disease	0.0001	0.00118	CcSEcCtD
Bromocriptine—ADRA2A—central nervous system—Alzheimer's disease	9.9e-05	0.0022	CbGeAlD
Bromocriptine—ADRA2C—brain—Alzheimer's disease	9.85e-05	0.00219	CbGeAlD
Bromocriptine—Urticaria—Rivastigmine—Alzheimer's disease	9.85e-05	0.00116	CcSEcCtD
Bromocriptine—Abdominal pain—Rivastigmine—Alzheimer's disease	9.8e-05	0.00115	CcSEcCtD
Bromocriptine—Body temperature increased—Rivastigmine—Alzheimer's disease	9.8e-05	0.00115	CcSEcCtD
Bromocriptine—ABCB1—telencephalon—Alzheimer's disease	9.7e-05	0.00216	CbGeAlD
Bromocriptine—ADRA2A—cerebellum—Alzheimer's disease	9.68e-05	0.00215	CbGeAlD
Bromocriptine—Diarrhoea—Donepezil—Alzheimer's disease	9.55e-05	0.00112	CcSEcCtD
Bromocriptine—Dizziness—Donepezil—Alzheimer's disease	9.23e-05	0.00109	CcSEcCtD
Bromocriptine—Asthenia—Memantine—Alzheimer's disease	9.09e-05	0.00107	CcSEcCtD
Bromocriptine—Asthenia—Rivastigmine—Alzheimer's disease	8.89e-05	0.00105	CcSEcCtD
Bromocriptine—Vomiting—Donepezil—Alzheimer's disease	8.87e-05	0.00104	CcSEcCtD
Bromocriptine—Rash—Donepezil—Alzheimer's disease	8.8e-05	0.00104	CcSEcCtD
Bromocriptine—Dermatitis—Donepezil—Alzheimer's disease	8.79e-05	0.00103	CcSEcCtD
Bromocriptine—Headache—Donepezil—Alzheimer's disease	8.74e-05	0.00103	CcSEcCtD
Bromocriptine—HTR2A—nervous system—Alzheimer's disease	8.74e-05	0.00195	CbGeAlD
Bromocriptine—Diarrhoea—Memantine—Alzheimer's disease	8.67e-05	0.00102	CcSEcCtD
Bromocriptine—Diarrhoea—Rivastigmine—Alzheimer's disease	8.48e-05	0.000998	CcSEcCtD
Bromocriptine—HTR2A—central nervous system—Alzheimer's disease	8.42e-05	0.00187	CbGeAlD
Bromocriptine—Dizziness—Memantine—Alzheimer's disease	8.38e-05	0.000986	CcSEcCtD
Bromocriptine—Nausea—Donepezil—Alzheimer's disease	8.29e-05	0.000976	CcSEcCtD
Bromocriptine—HTR2A—cerebellum—Alzheimer's disease	8.23e-05	0.00183	CbGeAlD
Bromocriptine—Dizziness—Rivastigmine—Alzheimer's disease	8.2e-05	0.000965	CcSEcCtD
Bromocriptine—CYP3A4—nervous system—Alzheimer's disease	8.09e-05	0.0018	CbGeAlD
Bromocriptine—Vomiting—Memantine—Alzheimer's disease	8.06e-05	0.000948	CcSEcCtD
Bromocriptine—Rash—Memantine—Alzheimer's disease	7.99e-05	0.000941	CcSEcCtD
Bromocriptine—Dermatitis—Memantine—Alzheimer's disease	7.98e-05	0.00094	CcSEcCtD
Bromocriptine—Headache—Memantine—Alzheimer's disease	7.94e-05	0.000934	CcSEcCtD
Bromocriptine—Vomiting—Rivastigmine—Alzheimer's disease	7.88e-05	0.000928	CcSEcCtD
Bromocriptine—ADRA2A—brain—Alzheimer's disease	7.86e-05	0.00175	CbGeAlD
Bromocriptine—Rash—Rivastigmine—Alzheimer's disease	7.82e-05	0.00092	CcSEcCtD
Bromocriptine—Dermatitis—Rivastigmine—Alzheimer's disease	7.81e-05	0.000919	CcSEcCtD
Bromocriptine—CYP3A4—central nervous system—Alzheimer's disease	7.79e-05	0.00173	CbGeAlD
Bromocriptine—Headache—Rivastigmine—Alzheimer's disease	7.77e-05	0.000914	CcSEcCtD
Bromocriptine—Nausea—Memantine—Alzheimer's disease	7.53e-05	0.000886	CcSEcCtD
Bromocriptine—Nausea—Rivastigmine—Alzheimer's disease	7.36e-05	0.000867	CcSEcCtD
Bromocriptine—HTR2A—brain—Alzheimer's disease	6.68e-05	0.00149	CbGeAlD
Bromocriptine—ABCB1—nervous system—Alzheimer's disease	5.73e-05	0.00128	CbGeAlD
Bromocriptine—ABCB1—central nervous system—Alzheimer's disease	5.52e-05	0.00123	CbGeAlD
Bromocriptine—ABCB1—cerebellum—Alzheimer's disease	5.39e-05	0.0012	CbGeAlD
Bromocriptine—ABCB1—brain—Alzheimer's disease	4.38e-05	0.000975	CbGeAlD
Bromocriptine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.71e-06	3.37e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	1.7e-06	3.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	1.7e-06	3.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	1.7e-06	3.35e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—LPL—Alzheimer's disease	1.69e-06	3.34e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.68e-06	3.31e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-06	3.3e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.67e-06	3.29e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	1.66e-06	3.28e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.65e-06	3.26e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	1.65e-06	3.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	1.65e-06	3.25e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	1.65e-06	3.25e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	1.64e-06	3.24e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—INS—Alzheimer's disease	1.64e-06	3.23e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.64e-06	3.23e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.63e-06	3.23e-05	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.63e-06	3.22e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	1.63e-06	3.21e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.62e-06	3.2e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	1.62e-06	3.2e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.62e-06	3.19e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.61e-06	3.18e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	1.61e-06	3.18e-05	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.61e-06	3.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	1.61e-06	3.18e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.61e-06	3.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.6e-06	3.16e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	1.59e-06	3.15e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	1.59e-06	3.15e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	1.59e-06	3.14e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	1.59e-06	3.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.59e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.59e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.58e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.58e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	1.58e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	1.58e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	1.58e-06	3.13e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.58e-06	3.12e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.58e-06	3.12e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.57e-06	3.11e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.57e-06	3.1e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.56e-06	3.09e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.56e-06	3.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.56e-06	3.08e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—Alzheimer's disease	1.56e-06	3.08e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	1.56e-06	3.08e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.55e-06	3.07e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	3.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	1.54e-06	3.04e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.53e-06	3.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.53e-06	3.01e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.53e-06	3.01e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.52e-06	3.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.49e-06	2.93e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.49e-06	2.93e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.49e-06	2.93e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.48e-06	2.92e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.48e-06	2.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.47e-06	2.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.47e-06	2.9e-05	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.47e-06	2.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.47e-06	2.89e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.47e-06	2.89e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.46e-06	2.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	2.88e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	2.88e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.46e-06	2.88e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.45e-06	2.87e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.45e-06	2.87e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	2.87e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-06	2.87e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.45e-06	2.86e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.44e-06	2.85e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.44e-06	2.85e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-06	2.84e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.44e-06	2.84e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.43e-06	2.82e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.42e-06	2.81e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOE—Alzheimer's disease	1.42e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.42e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.41e-06	2.79e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.41e-06	2.78e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.41e-06	2.78e-05	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.4e-06	2.77e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.4e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.4e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.39e-06	2.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.38e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.38e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.38e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.37e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.37e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.36e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.35e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.35e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.35e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.34e-06	2.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.34e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.34e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.33e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.33e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.32e-06	2.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	2.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.32e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.31e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.29e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.28e-06	2.52e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.27e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.27e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.27e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	2.48e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.24e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.24e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.23e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.23e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	2.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.22e-06	2.41e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.22e-06	2.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.22e-06	2.4e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—INS—Alzheimer's disease	1.21e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.21e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.21e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.21e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.2e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.2e-06	2.37e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.2e-06	2.37e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.19e-06	2.36e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.19e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.19e-06	2.34e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.18e-06	2.33e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.18e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.17e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	2.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.17e-06	2.3e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.15e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.15e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.14e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.14e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.14e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.13e-06	2.24e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	2.23e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.12e-06	2.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.12e-06	2.22e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.12e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.12e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.1e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.1e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.1e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.1e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.1e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.09e-06	2.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.09e-06	2.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.08e-06	2.14e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.08e-06	2.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.08e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.08e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.08e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	2.11e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.06e-06	2.1e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.05e-06	2.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.05e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.04e-06	2.06e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.04e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.03e-06	2.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	2.02e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	2.02e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.02e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.02e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.02e-06	2e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.01e-06	1.99e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.01e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	9.97e-07	1.97e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	9.88e-07	1.95e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	9.87e-07	1.95e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	9.73e-07	1.92e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	9.72e-07	1.92e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—INS—Alzheimer's disease	9.68e-07	1.91e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	9.5e-07	1.88e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	9.48e-07	1.87e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.4e-07	1.85e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	9.36e-07	1.85e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	9.36e-07	1.85e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	9.35e-07	1.85e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	9.31e-07	1.84e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	9.28e-07	1.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	9.27e-07	1.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	9.23e-07	1.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	9.15e-07	1.81e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	8.91e-07	1.76e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	8.86e-07	1.75e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.78e-07	1.73e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	8.75e-07	1.73e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.75e-07	1.73e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	8.71e-07	1.72e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.67e-07	1.71e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	8.63e-07	1.7e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	8.63e-07	1.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	8.62e-07	1.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	8.53e-07	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	8.51e-07	1.68e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	8.49e-07	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	8.48e-07	1.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	8.45e-07	1.67e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	8.15e-07	1.61e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	8.11e-07	1.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	7.89e-07	1.56e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	7.86e-07	1.55e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	7.82e-07	1.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	7.79e-07	1.54e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	7.77e-07	1.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	7.77e-07	1.53e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	7.7e-07	1.52e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.62e-07	1.5e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	7.54e-07	1.49e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	7.52e-07	1.48e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	7.48e-07	1.48e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—INS—Alzheimer's disease	7.47e-07	1.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	7.28e-07	1.44e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	7.16e-07	1.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	7.16e-07	1.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	7.07e-07	1.4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	7.04e-07	1.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	7e-07	1.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	6.9e-07	1.36e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	6.61e-07	1.3e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.55e-07	1.29e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	6.5e-07	1.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	6.41e-07	1.27e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	6.36e-07	1.26e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.99e-07	1.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	5.91e-07	1.17e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.89e-07	9.65e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	3.9e-07	7.7e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.01e-07	5.95e-06	CbGpPWpGaD
